CHP and BMJU are at the Department of Neurology, VU Medical Center, Amsterdam, Netherlands The use of interferon beta and glatiramer acetate for the treatment of multiple sclerosis (MS) has, to some ...

From disease-modifying medications to rehabilitation strategies, choosing treatment for multiple sclerosis starts with understanding your options. Take an active role in managing your care. Verywell ...

Switching therapies is a common part of multiple sclerosis management and may be considered for several reasons.

In MS, immune system cells mistakenly attack myelin. With stem cell treatment, doctors use chemotherapy to destroy these existing immune cells. Then, they introduce the new stem cells, which are ...

Multiple sclerosis (MS) is a progressive autoimmune disease that affects the brain and spinal cord, impacting 2.8 million ...

Nevertheless, approval by WHO of the MSIF application will be a crucial first step to ensure that people with multiple sclerosis will be able to access appropriate treatment options in LMICs.

A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...

Background Treatment options for patients suffering from progressive forms of multiple sclerosis (MS) remain inadequate. Mast cells actively participate in the pathogenesis of MS, in part because ...

Despite dedicated research, multiple sclerosis remains a poorly understood disease with limited treatment options to ease symptoms. Through research in the Center for Multiple Sclerosis and Autoimmune ...